Thinkhat
Thinkhat is an HLS-focused venture studio founded in 2021 that builds and owns AI-native healthcare, life sciences and medical education companies. Headquartered in Puerto Rico with hubs in Boston and San Francisco, it operates eleven portfolio companies spanning therapeutics, diagnostics, clinical trials and digital health.
- Company typePrivate
- Founded2021
- HeadquartersWilmington, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Thinkhat does
Thinkhat is a healthcare, life sciences and education (HLS) focused venture studio that ideates, incubates and launches AI-native companies. Founded in 2021 and headquartered in San Juan, Puerto Rico with strategic hubs in Boston and San Francisco, the firm employs 110+ scientists, engineers, AI/ML specialists and venture builders, supported by 60+ advisors. The studio operates through three disclosed phases — Ideation (84% seed funding success rate, 3–5 ventures launched annually), Incubation (3–4x resource efficiency, >44% better results) and Illumination (33% faster exits, 2x speed to market) — and has built eleven wholly-owned portfolio companies spanning cellular reprogramming therapeutics (Renue Bio), AI-driven medical education (Socratic AI), voice-first clinical documentation (Noki), RNA therapeutics sequencing (nCode), a modular healthcare operating system (Enliv), a mental health AI companion (Orie), clinical trial orchestration (Samaras), an AI development SDK (Corus), CRISPR-based diagnostics (DxBio), remote monitoring (OnCare) and personalized health insights (Vytal).
The studio's core technology stack is AI-native and multimodal, covering speech/audio (Noki voice scribe), text and conversational agents (Orie, Socratic AI), generative AI for biology (Renue Bio), autonomous agentic orchestration (Samaras, Corus Synapse AI Engine), predictive analytics and pattern recognition (OnCare, EnlivOptimize), and CRISPR plus AI diagnostics (DxBio). Cross-portfolio infrastructure is provided through the Coru.ai SDK and HIPAA-compliant data and model warehouses, while the Enliv modular OS unifies EHR (EnlivRecords), billing (EnlivBill), coding (EnlivCode), optimization (EnlivOptimize) and security (EnlivGuard). API access exists via the Coru.ai SDK with documentation hosted at corus.dev.
Thinkhat's business model combines venture studio fees, equity ownership in portfolio companies, and co-development arrangements, with portfolio companies generating revenue through SaaS subscriptions (Enliv, Noki, Corus), platform/SDK access (Corus), therapeutic and diagnostic commercialization (Renue Bio, DxBio, nCode), and consumer-facing support (Orie, Vytal). Customer segments are diversified across Healthcare Providers, Life Sciences companies, Medical Education institutions, CROs, Healthcare AI Developers, and individuals with mental health needs. Distribution relies on direct outreach, the EIR Program as a talent and deal-sourcing channel, and an active digital presence via the thinkhat.ai website and LinkedIn. The firm reports $20M+ in capital deployed across the portfolio and closed a $1M funding round in May 2025.
Thinkhat firmographics
Firmographics- Name
- Thinkhat
- Legal name
- Thinkhat Software Inc.
- Website
- https://thinkhat.ai
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Thinkhat is an HLS-focused venture studio founded in 2021 that builds and owns AI-native healthcare, life sciences and medical education companies. Headquartered in Puerto Rico with hubs in Boston and San Francisco, it operates eleven portfolio companies spanning therapeutics, diagnostics, clinical trials and digital health.
- Ownership category
- akta.pro rank
Thinkhat industry classification
Industry- Product category
- Healthcare AI Venture Studio
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Prepackaged Software (7372), Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where Thinkhat is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Thinkhat business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Venture Studio Services: Partners with founders to build, launch, and scale ventures. Revenue generated through equity ownership in portfolio companies, studio fees, and co-development arrangements.
- Portfolio Company Equity: Thinkhat maintains equity stakes in ventures launched through the studio, generating returns upon exits or continued growth.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Thinkhat product offering
Product offeringCore offering
Thinkhat is a venture studio that engineers, funds, incubates, and scales AI/ML-driven startups focused on healthcare, life sciences, and medical education. It builds and manages a portfolio of companies delivering voice-based clinical documentation, cellular reprogramming therapeutics, RNA therapeutics discovery, modular healthcare operating systems, AI-driven medical education simulations, mental health companions, agentic clinical trial orchestration, AI development platforms, CRISPR diagnostics, remote health monitoring, and personalized health insights.
Product overview
Thinkhat operates as an HLS-focused venture studio that engineers healthcare, life sciences, and AI ventures from ideation to execution. The company builds and manages a portfolio of portfolio companies including Renue Bio (therapeutic platform for cellular reprogramming), Socratic AI (AI-driven medical education platform), Noki (voice-first AI copilot for healthcare providers), nCode (RNA therapeutics sequencing platform), Enliv (modular healthcare operating system with EHR, billing, coding, and compliance modules), Orie (AI mental health companion), Samaras (clinical trial orchestration), Corus (AI development platform with SDK), DxBio (CRISPR-based diagnostics), OnCare (remote health monitoring), and Vytal (personalized health insights). The venture studio also runs an EIR Program for entrepreneurs and supports ventures through ideation, incubation, and illumination phases with 84% seed funding success rate.
Differentiator
Problem solved
Functional benefit
Products and services
- Thinkhat Venture Studio HLS-focused venture studio that engineers healthcare and life sciences ventures from ideation to execution, providing shared platform, AI/ML capabilities, research, design, and strategic capital for building scalable companies. Targets founders in healthcare AI, biotech, and digital health and reports 84% seed funding success with 3-5 ventures launched annually.
- Noki AI Voice-First Copilot Voice-first AI companion for healthcare providers that optimizes the entire patient encounter workflow from engagement to post-encounter care, automating documentation, administrative workflows, and real-time clinical support with the goal of reducing physician documentation time by up to 70%.
- Renue Bio Therapeutic Platform Therapeutic platform that harnesses the regenerative potential of reprogramming factors (Yamanaka factors, OSKL) and small molecules to rejuvenate cells and tag damaged cells for debris removal, employing partial reprogramming to reverse or halt disease at its biological root for life sciences and biotech customers.
- Socratic AI Medical Education Platform AI-driven longitudinal medical education platform that unifies tutoring, training, testing, and tracking into an adaptive learning arc, offering personalized OSCE-style simulations, continuous competency assessment, and real-time Socratic coaching for practice-ready mastery, targeted at medical schools and training institutions.
- nCode Sequences as a Service (SqAAS) Sequences as a Service (SqAAS) platform that significantly reduces the time from discovery to preclinical stages for RNA therapeutics, targeted at biotech and pharma R&D teams.
- Enliv Modular Healthcare OS Modular healthcare operating system that unifies EHR, billing, coding, and compliance into a single intelligent AI-powered platform for healthcare providers, including EnlivRecords (EHR), EnlivOptimize (AI analytics), EnlivBill (billing), EnlivCode (medical coding), and EnlivGuard (security/compliance).
- Orie AI Mental Health Companion AI-powered compassionate companion platform offering real-time, personalized support for mental health, chronic conditions, or wellbeing challenges via custom-trained AI avatars, with multi-language (English and Spanish) access, daily check-ins, mood tracking, and human escalation when needed.
- Samaras Clinical Trial Orchestration Agentic orchestration layer that connects fragmented clinical trial systems and applies contextual clinical and protocol intelligence across end-to-end trial workflows, informed by over 20 years of operational data, targeted at CROs and trial sponsors.
- Corus Agentic Data Inference Platform Agentic Data Inference Platform and AI-native healthcare innovation platform providing a full-stack SDK (Coru.ai SDK), data and model warehouses, automation tooling, Synapse AI Engine, and HIPAA-compliant compliance infrastructure for building, deploying, and scaling intelligent medical applications.
- DxBio CRISPR Diagnostics Next-generation diagnostics platform combining CRISPR-based assays, AI analytics, and microfluidic automation to detect antimicrobial resistance (AMR) and early pathogen threats with speed, precision, and affordability for healthcare and life sciences customers.
- OnCare Remote Health Monitoring Remote healthcare platform that uses pattern recognition and machine learning to deliver remote health monitoring services for healthcare providers and patients.
- Vytal Personalized Health Insights Health platform leveraging AI, Real World Evidence, and Data to provide personalized health insights that empower individuals to live longer, healthier lives.
Quantifiable outcome
- 84% seed funding success rate for portfolio ventures
- +6 more outcomes
Companies that use Thinkhat
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Thinkhat technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability16 records
Feature8 records
Thinkhat partnerships and signals
Strategic signalScale indicators10 records
Recent moves6 records
Expansion highlights6 records
Thinkhat competitors and assessment
Company assessmentDirect peers
- Suki AI: Voice-enabled AI assistant for clinicians that automates documentation and EHR workflows. Closely comparable to Noki and a useful pricing/benchmarking reference for that venture.
- Benchling: Cloud R&D platform for life sciences with shared data model, AI/ML, and developer tooling. Directly comparable to Corus (AI SDK/model warehouses) and to portions of nCode's RNA therapeutics workflow.
- Abridge: Leading AI medical scribe that automates clinical documentation and conversation summarization. The most direct competitor to Thinkhat's Noki portfolio company and the strongest read on Noki's commercial ceiling.
- Headspace Health: Consumer and enterprise mental-wellness platform with AI-guided support, content, and coaching. Directly comparable to Orie's AI mental-health companion and represents the dominant scale competitor in this category.
- Medable: Decentralized clinical-trial platform connecting sponsors, sites, and patients with eCOA/eConsent and orchestration. Directly comparable to Samaras' agentic clinical-trial orchestration layer.
- Science 37: Decentralized/remote clinical trial operator with proprietary orchestration technology. Directly comparable to Samaras on the operational side of clinical trial execution.
- Insitro: AI-native drug discovery company combining machine learning with cellular reprogramming and high-throughput biology. Highly comparable to Thinkhat's Renue Bio (cellular reprogramming) and to the broader AI-for-life-sciences thesis.
Broad incumbents
- Flagship Pioneering: The archetype healthcare/life-sciences venture studio that originates and incubates biotech companies. Flagship is a broader incumbent with deeper capital, but the closest comparable to Thinkhat's venture-studio model applied to HLS+AI.
- Veeva Systems: Dominant vertical SaaS provider for life sciences and clinical trials (CTMS, eTMF, RIM). Broader incumbent against Samaras and against any clinical/regulatory module Thinkhat builds into Corus or Enliv.
- Tempus Labs: AI-powered precision medicine platform that integrates clinical and molecular data for R&D and care delivery. Broad incumbent comparable to the Corus/Vytal data-inference and real-world-evidence thesis within Thinkhat's portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Thinkhat social profiles
Digital presenceThinkhat financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thinkhat leadership team
Management profileNumber of profiles
Profiles14 records
Thinkhat subsidiaries and ownership
Company hierarchySubsidiaries11 records
Thinkhat funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thinkhat M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thinkhat
What does Thinkhat do?
Thinkhat is a venture studio that engineers, funds, incubates, and scales AI/ML-driven startups focused on healthcare, life sciences, and medical education. It builds and manages a portfolio of companies delivering voice-based clinical documentation, cellular reprogramming therapeutics, RNA therapeutics discovery, modular healthcare operating systems, AI-driven medical education simulations, mental health companions, agentic clinical trial orchestration, AI development platforms, CRISPR diagnostics, remote health monitoring, and personalized health insights.
Is Thinkhat a public or private company?
Thinkhat is a private company. It is classified as venture growth investor backed and is currently operating.
When was Thinkhat founded?
Thinkhat was founded in 2021. It employs 51 to 100 people.
Where is Thinkhat based?
Thinkhat is headquartered in Wilmington, United States, in the North America region.
How does Thinkhat make money?
Two revenue lines are on record. Venture Studio Services are the primary driver. The others are portfolio Company Equity.
Who are Thinkhat's main competitors?
Direct peers on record are Suki AI, Benchling, Abridge, Headspace Health, Medable, Science 37 and Insitro. Broad incumbents are Flagship Pioneering, Veeva Systems and Tempus Labs.
Does Thinkhat have an API?
Yes. Corus provides a full-stack SDK (Coru.ai SDK) with tools, libraries, and frameworks for developers to build intelligent, autonomous healthcare applications. The platform offers data warehouses, automation tooling, and compliance infrastructure within a HIPAA-compliant environment to enable healthcare teams to build, deploy, and scale AI applications rapidly. Developer documentation is at corus.dev.
What industry is Thinkhat in?
Thinkhat's product category is Healthcare AI Venture Studio. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 7372.